Related Experiment Videos
The clinical pharmacology of beta-adrenoceptor-blocking drugs
Progress in Cardiovascular Diseases
|November 1, 1976
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Concise Guide to PHARMACOLOGY 2013/14: overview.
British journal of pharmacology·2014
Intracellular drug concentrations.
Clinical pharmacology and therapeutics·2013
Metabolism of terbutaline in man and dog.
British journal of clinical pharmacology·2012
Acute effects of varying doses of propranolol upon oxygen haemoglobin affinity in man.
British journal of clinical pharmacology·2012
Lapatinib-induced liver injury characterized by class II HLA and Gilbert's syndrome genotypes.
Clinical pharmacology and therapeutics·2012
Clinical pharmacology in the molecular era.
Clinical pharmacology and therapeutics·2008
Genetic testing for dilated and arrhythmogenic cardiomyopathies - A primer for cardiologists.
Progress in cardiovascular diseases·2026
Dynamic pericoronary fat attenuation as a non-invasive marker of CAV progression after heart transplantation.
Progress in cardiovascular diseases·2026
Current state of carotid artery interventions: Clinical trial results and real-world challenges.
Progress in cardiovascular diseases·2026
Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM.
Progress in cardiovascular diseases·2026
Joint associations of Interleukin-6 and apolipoprotein B with major adverse cardiovascular events in the UK biobank.
Progress in cardiovascular diseases·2026
Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.
The Journal of membrane biology·2026
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026